In last trading session, BioAge Labs Inc (NASDAQ:BIOA) saw 0.43 million shares changing hands with its beta currently measuring 0. Company’s recent per share price level of $4.59 trading at -$0.19 or -3.97% at ring of the bell on the day assigns it a market valuation of $164.55M. That closing price of BIOA’s stock is at a discount of -479.96% from its 52-week high price of $26.62 and is indicating a premium of 16.12% from its 52-week low price of $3.85. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 0.28 million shares which gives us an average trading volume of 755.01K if we extend that period to 3-months.
BioAge Labs Inc (NASDAQ:BIOA) trade information
Upright in the red during last session for losing -3.97%, in the last five days BIOA remained trading in the red while hitting it’s week-highest on Monday, 01/27/25 when the stock touched $4.59 price level, adding 15.63% to its value on the day. BioAge Labs Inc’s shares saw a change of -20.73% in year-to-date performance and have moved -15.00% in past 5-day. BioAge Labs Inc (NASDAQ:BIOA) showed a performance of -18.90% in past 30-days. Number of shares sold short was 2.06 million shares which calculate 1.97 days to cover the short interests.
Wall Street analysts have assigned a consensus price target of 40 to the stock, which implies a rise of 88.52% to its current value. Analysts have been projecting 7 as a low price target for the stock while placing it at a high target of 45. It follows that stock’s current price would drop -52.51% in reaching the projected high whereas dropping to the targeted low would mean a loss of -52.51% for stock’s current value.
On the other hand, AB Cap Fd.-AB Small Cap Growth Port and Principal Small Cap Growth Fd I are the top two Mutual Funds which own company’s shares. As of Nov 30, 2024 , the former fund manager was holding 606.05 shares of worth $2.78 million or 1.69% of the total outstanding shares. The later fund manager was in possession of 274.39 shares on Oct 31, 2024 , making its stake of worth around $1.26 million in the company or a holder of 0.77% of company’s stock.
